Fampridine-induced changes in walking kinetics are associated with clinical improvements in patients with multiple sclerosis
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the Neurological Sciences"
DOI: 10.1016/j.jns.2020.116978
Abstract: Gait dysfunction is common in patients with multiple sclerosis (PwMS). Treatment with prolonged-release fampridine (PR-fampridine) improves walking ability in some PwMS. Associated fampridine-induced changes in the walking pattern are still poorly understood but may provide… read more here.
Keywords: induced changes; fampridine induced; changes walking; multiple sclerosis ... See more keywords